BIVICTRIX THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.25 GBX | 0.00% |
|
+2.08% | +16.67% |
| 06-13 | EARNINGS AND TRADING: Dialight trades in line; Petards swings to loss | AN |
| 06-13 | BiVictriX Therapeutics' Leukemia Treatment Shows Favorable Safety Profile | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12.82M | - | - | - | - | - | |
| 53.67B | - | |||||
| 38.86B | ||||||
| 38.76B | ||||||
| 27.27B | ||||||
| 25.91B |
